Rick R Drake
Papers
1
Total Citations
22
H-Index
1
About
Rick R. Drake has made foundational contributions to clinical proteomics, with a focus on advancing mass spectrometry-based methods for cancer biomarker discovery. His most-cited work, the 2008 paper "MALDI/SELDI Protein Profiling of Serum for the Identification of Cancer Biomarkers" (22 citations), addresses a critical challenge in the field: visualizing the full depth of the serum proteome in a high-throughput manner. Drake’s research centers on integrating MALDI and SELDI technologies to enable rapid, reproducible profiling of protein expression patterns directly from patient serum. By combining higher throughput with the ability to detect differential protein levels, his methodologies have helped pave the way for non-invasive cancer diagnostics and early detection strategies. Though his citation count reflects a focused, emerging impact, Drake’s work is notable for its methodological rigor and its role in bridging proteomic technology with clinical application. His contributions continue to inform researchers seeking to translate protein signatures into practical screening tools, making him a key figure in the ongoing effort to harness the serum proteome for precision oncology.
Research Focus
Key Achievements
Top Papers
- 1